- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Bausch & Lomb plans to double size of R&D center
Bausch & Lomb announced it will nearly double the size of its main research and development (R&D) center in Rochester, NY. The new two-story, 75,000-square-foot glass-and-brick wing will house laboratories and offices. It also will allow room for a future 25,000-square-foot addition.
Bausch & Lomb announced it will nearly double the size of its main research and development (R&D) center in Rochester, NY. The new two-story, 75,000-square-foot glass-and-brick wing will house laboratories and offices. It also will allow room for a future 25,000-square-foot addition.
The $35 million project includes $25 million for new construction and $10 million for renovations, equipment, and machinery, the company said in a prepared statement. The company is projected to add as many as 200 research jobs over the next 2 years.
The expansion "demonstrates our commitment to continue to develop innovative products to help people see, and will facilitate our plans to increase our presence in the nearly $20 billion global eye-health market," said Praveen Tyle, PhD, senior vice president and chief scientific officer of Bausch & Lomb.
